An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial.
暂无分享,去创建一个
M. Gent | V. Marzinotto | P. Massicotte | M. Andrew | Anthony K. C. Chan | J. Julian | K. Shields | B. Szechtman